CVR 30721632Private limited company (ApS)Forskning og eksperimentel udvikling indenfor bioteknologi (721100)Kongevejen 371, 2840 HolteFounded 7 Jul 2007
Compare withsimilar companiesanother companyits industry
INAGEN ApS
The newest trades with a company on a side are on the latest property trades.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Cite as: INAGEN ApS, https://dandex.ai/company/30721632/inagen. Source: Dandex, from CVR, read 22 Nov 2026.
Dandex is Danish Company Data. Connect it once and ask about INAGEN ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Dandex has an MCP server at https://dandex.ai/mcp and a REST API at https://dandex.ai/api/v1.
Set up DandexEmployees
0
CVR, 2012
Gross profit
54.3K
DKK, annual report 2014
Result
-1.1M
DKK, annual report 2014
Equity
-12.1M
DKK, annual report 2014
Novo Holdings A/SCVR 24257630, 50% to under 66.7% of capital and votes, until 31 Mar 2016
TNK BIOTECH ApSCVR 30691911, 10% to under 15% of capital and votes, until 31 Mar 2016
Thomas Nitschke Kledaluntil 18 Mar 2015
No current owner is registered.
CVR 2425763050% to under 66.7% of capital and votesclass B, C21 Dec 2009 to 31 Mar 2016
CVR 1007301420% to under 25% of capital and votesclass A, B29 Dec 2009 to 31 Jan 2014
CVR 3069191110% to under 15% of capital and votesclass A7 Jul 2007 to 31 Mar 2016
CVR lists no current officers for this company.
Founded 7 Jul 2007.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
2012, annual: 0 employees, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 2008 | 2009 | Q1 2010 | Q2 2010 | Q3 2010 | Q4 2010 | 2011 | 2012 |
|---|---|---|---|---|---|---|---|---|
| Employees | 3 | 6 | No count | No count | No count | No count | 6 | 0 |
| FTE | 1 | 4 | 5 | 5 | 5 | 5 | 5 | 1 |
| Series | Annual | Annual | Quarterly | Quarterly | Quarterly | Quarterly | Annual | Annual |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest 2012, published 24 Jun 2014.
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2010 | 2011 | 2012 | 2013 | 2014 |
|---|---|---|---|---|---|
| Gross profit | Not reported | Not reported | Not reported | Not reported | 54 |
| Result for the year | Not reported | Not reported | Not reported | Not reported | -1,071 |
| Equity | Not reported | Not reported | Not reported | Not reported | -12,145 |
| Total assets | Not reported | Not reported | Not reported | Not reported | 257 |
Amounts in DKK. Cash price is per DKK 1 of nominal capital, which a share split does not move. Implied value is the whole capital after the step at its cash price, not a valuation.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| IncreaseCashPaid in 5,499,989, cash price 31.00, implied value 15,766,569 | 31.00 | 5,499,989 | 15,766,569 | 508,599 | |
| IncreaseCashPaid in 4,049,995, cash price 31.00, implied value 10,266,580 | 31.00 | 4,049,995 | 10,266,580 | 331,180 | |
| IncreaseCashPaid in 949,995, cash price 31.00, implied value 6,216,585 | 31.00 | 949,995 | 6,216,585 | 200,535 | |
| IncreaseCashPaid in 1,770,013, cash price 39.43, implied value 6,698,763 | 39.43 | 1,770,013 | 6,698,763 | 169,890 | |
| FoundingNot read from the announcement | None | None | None | 125,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2010 | 2011 | 2012 | 2013 | 2014 |
|---|---|---|---|---|---|
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | ||||
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Source: CVR, read 22 Nov 2026.
18 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Likvidation sluttet, og virksomheden opløst
Likvidatorer:
Fratrådte:
Jan Bjerrum Bach, den 31.03.2016.
Revision:
Fratrådte:
DANSK REVISION ROSKILDE, GODKENDT REVISIONSAKTIESELSKAB, den 31.03.2016.
CVR-nummer
30721632.
NAVN:
INAGEN ApS.
Adresse: c/o Jusmedico Advokatanpartsselskab, Kongevejen 371, 2840 Holte.
Kommune: Rudersdal.
Likvidation vedtaget 18.03.2015
Likvidatorer:
Tiltrådte:
Jan Bjerrum Bach, den 18.03.2015.
Bestyrelse:
Fratrådte:
Stephan Christgau (formand), den 18.03.2015, Thomas Nitschke Kledal, den 18.03.2015.
Direktion:
Fratrådte:
Thomas Nitschke Kledal (adm. dir), den 18.03.2015.
Virksomheden tegnes af en likvidator.
Selskabets kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
CVR-nummer
30721632.
NAVN:
INAGEN ApS.
Adresse: Asylgade 7A, 2800 Kgs. Lyngby.
Kommune: Lyngby-Taarbæk.
Ny adresse: c/o Jusmedico Advokatanpartsselskab, Kongevejen 371, 2840 Holte
Ny kommune: Rudersdal
Ny adresse:
Asylgade 7A, 2800 Kongens Lyngby.
Vedtægter ændret:
18.05.2012.
Bestyrelse:
Tiltrådt som formand:
Stephan Christgau, den 18.05.2012.
Udtrådt af bestyrelsen:
Peter Samuel Wulff, den 18.05.2012, Christian Ellebæk Elling, den 18.05.2012.
Vedtægter ændret:
30.11.2010.
Ny adresse:
Diplomvej 378, 2800 Kongens Lyngby.
Ny kommune:
Lyngby-Taarbæk.
Vedtægter ændret:
26.05.2010.
Revision:
Udtrådt af revisionen:
ERNST & YOUNG P/S, den 07.05.2010.
Indtrådt i revisionen:
CVR-NR. 26052394 ERNST & YOUNG P/S, Gyngemose Parkvej 50, 2860 Søborg, den 07.05.2010.
Vedtægter ændret:
14.12.2009.
Kapitalforhøjelse:
kr. 177.419,00 indbetalt kontant, kurs 3.100,00.
Kapitalen udgør herefter kr. 508.599,00.
Kapitalen er opdelt i klasser:
A kr. 125.000,00, B kr. 206.180,00, C kr. 177.419,00.
Vedtægter ændret:
25.02.2009.
Kapitalforhøjelse:
kr. 130.645,00 indbetalt kontant, kurs 3.100,00,
Klasser:
B kr. 130.645,00.
Kapitalen udgør herefter kr. 331.180,00.
Kapitalen er opdelt i klasser:
A kr. 125.000,00, B kr. 206.180,00.
Vedtægter ændret:
12.11.2008.
Ny adresse:
c/o Risø DTU, Frederiksborgvej 399, Himmelev, 4000 Roskilde.
Ny kommune:
Roskilde.
Kapitalforhøjelse:
kr. 30.645,00 indbetalt kontant, kurs 3.100,00,
Klasser:
B kr. 30.645,00.
Kapitalen udgør herefter kr. 200.535,00.
Kapitalen er opdelt i klasser:
A kr. 125.000,00, B kr. 75.535,00.
Bestyrelse:
Fratrådt som formand, men forbliver i bestyrelsen: Leif Helth Jensen, den 12.11.2008.
Udtrådt af bestyrelsen:
Jørgen Søberg Petersen, den 12.11.2008.
Indtrådt i bestyrelsen:
Adm. direktør Peter Samuel Wulff (formand), den 12.11.2008, Stephan Christgau, den 12.11.2008.
Direktion:
Indtrådt i direktionen:
Thomas Nitschke Kledal (adm. dir), den 12.11.2008.
Selskabet tegnes af bestyrelsesformanden i forening med den administrerende direktør, bestyrelsesformanden i forening med et andet bestyrelsesmedlem eller af den samlede bestyrelse.
Revision:
Udtrådt af revisionen:
CVR-NR. 12523246 GRANT THORNTON, STATSAUTORISERET REVISIONSAKTIESELSKAB, den 28.01.2008.
Indtrådt i revisionen:
ERNST & YOUNG STATSAUTORISERET REVISIONSAKTIESELSKAB, Ro's Torv 53, 4000 Roskilde, den 28.01.2008.
Vedtægter ændret:
28.08.2007.
Kapitalforhøjelse:
kr. 44.890,00 indbetalt kontant, kurs 3.943,00.
Kapitalen udgør herefter kr. 169.890,00.
Kapitalen er opdelt i klasser:
A kr. 125.000,00, B kr. 44.890,00.
Bestyrelse:
Indtrådt i bestyrelsen:
Direktør Leif Helth Jensen (formand), den 28.08.2007, Christian Ellebæk Elling, den 28.08.2007, Thomas Nitschke Kledal, den 28.08.2007, Sean Arthur Macdonald, den 28.08.2007, Jørgen Søberg Petersen, den 28.08.2007.
Direktion:
Udtrådt af direktionen:
Thomas Nitschke Kledal, den 28.08.2007.
Selskabet tegnes af bestyrelsesformanden sammen med den administrerende direktør eller bestyrelsesformanden sammen med et andet bestyrelsesmedlem eller af den samlede bestyrelse.
Stiftelsesdato:
07.07.2007.
Seneste vedtægtsdato:
07.07.2007.
Kapital:
kr. 125.000,00.
Indbetalingsmåde:
kontant kr. 85.000,00 til kurs 100,00, i værdier kr. 40.000,00 til kurs 100,00.
Stiftere:
Mette Marie Roed, den 07.07.2007, CVR-NR. 25942167 NW BIOTECH INVEST ApS, Skt. Jakobs Gade 9, 3. th., 2100 København Ø, den 07.07.2007, CVR-NR. 30691911 TNK INVEST ApS, Sønderskovvej 20, 4180 Sorø, den 07.07.2007.
Direktion:
Thomas Nitschke Kledal, den 07.07.2007.
Selskabet tegnes af en direktør.
Revision:
CVR-NR. 12523246 GRANT THORNTON, STATSAUTORISERET REVISIONSAKTIESELSKAB, Stockholmsgade 45, 2100 København Ø, den 07.07.2007.
Første regnskabsår:
07.07.2007 - 31.12.2008.
Regnskabsår:
01.01 - 31.12.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 22 Nov 2026.
What Pro holds for INAGEN ApS:
Have Pro? Sign in.
P-number 1013464363Kongevejen 371, 2840 Holte